European Pharmacopoeia 5th Ed. Main Volume 5.0, 2005
The purpose of the Pharmacopoeia is to promote public health, by the provision of recognised common standards for use by healthcare professionals and others concerned with the quality of medicines.
The monographs and other texts are designed to be appropriate to the needs of regulatory authorities, those engaged in the control of quality, and the manufacturers of starting materials and medicinal products.
The Pharmacopoeia of the United States of America: Facsimile of the First Edition (1820)
The Pharmacopoeia of the United States of America: (The United States Pharmacopoeia). By General Medical Convention, United States Pharmacopeial Convention Committee of Revision, United States Pharmacopœial Convention, General Convention for the Formation of the American Pharmacopoeia, National Convention for Revising the Pharmacopoeia Published by United States Pharmacopoeial Convention, Inc., 1820-1975., 1820European Pharmacopoeia, 4th edition
The European Pharmacopoeia is a single reference work for the quality control of medicines in Europe. Several legal texts make the European Pharmacopoeia mandatory:A Convention on the Elaboration of a European Pharmacopoeia ratified in 2003 by 31 European countries and the European Union; European Union directives 2001/83/EC and 2001/82/EC,on medicines for human use and for veterinary use, respectively, maintain the mandatory character of European Pharmacopoeia specifications on medicines as regards their qualitative and quantitative composition and the tests to be carried out on these medicines, the raw materials used in production and the intermediates of synthesis. All producers of medicines or substances for pharmaceutical use therefore must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe. The texts of the European Pharmacopoeia are legally binding and compliance is enforced by the administrative or juridical authorities. The national authorities of the member states are bound to apply them if necessary replacing any national monograph on the same subject.The 4th Edition consists of an initial volume 2002 (4.0) and a collection of 8 non-cumulative supplements (4.1) published three times a year following the decisions of each session of the European Pharmacopoeia Commission. With supplement 4.6, the 4th Edition comprises 1750 specific monographs, 285 general methods illustrated by figures or chromatograms and 2140 reagents. Every 4 months a new volume enters into force.
The International Pharmacopoeia, Third Edition
Presents an historical account of the Pharmacopoeia and describes methods and procedures for the quality control of pharmaceutical substances and dosage forms, including a special section on quality control of anti-malarials.Saturday, January 9, 2010
British National Formulary (BNF) 54: September 2007
Compiled with the advice of clinical experts, this essential reference provides up-to-date guidance on prescribing, dispensing and administering medicines. The BNF details medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects, dosage and relative costs. Updated in print every six months, the BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines The BNF is also available online as part of Medicines Complete, on PDA and on also CD-ROM for
Fiedler Encyclopedia of Excipients: For Pharmaceuticals, Cosmetics and Related Areas
download
The two-volume encyclopedia offers a detailed description of properties, analyses and characteristic data for more than 17,000 excipients used in the manufacture of pharmaceuticals, cosmetics and related products. In addition, pharmacological and toxicological properties as well as allergy-inducing reactions are evaluated. Information on manufacturers is given in a directory at the end of the second volume.
Japanese Pharmacopoeia (Jp Xiv) (Pharmacopoeia of Japan)
British Pharmacopoeia 2007
download
alternate link
http://w19.easy-share.com/1903253289.html
http://w19.easy-share.com/1903253294.html
http://w19.easy-share.com/1903253303.html
http://w19.easy-share.com/1903253301.html
http://w19.easy-share.com/1903253294.html
http://w19.easy-share.com/1903253303.html
http://w19.easy-share.com/1903253301.html
The British Pharmacopoeia (BP) 2007 is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK quality standards. It is an essential reference for anyone involved in pharmaceutical Research & Development, manufacturing and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy.
The BP is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition package contains a boxed five volume set with a separate Veterinary volume, a CD-ROM and access to a comprehensible, regularly updated website. Both the CD-ROM and online formats are easy to network for access across your organisation.
There will not be an edition of the BP entitled 'British Pharmacopoeia 2006'. In order to improve the alignment of the published edition with the effective date of its contents, the forthcoming edition is entitled 'British Pharmacopoeia 2007'.
Key features:
The BP is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition package contains a boxed five volume set with a separate Veterinary volume, a CD-ROM and access to a comprehensible, regularly updated website. Both the CD-ROM and online formats are easy to network for access across your organisation.
There will not be an edition of the BP entitled 'British Pharmacopoeia 2006'. In order to improve the alignment of the published edition with the effective date of its contents, the forthcoming edition is entitled 'British Pharmacopoeia 2007'.
Key features:
- Extensive Revisions including 30 new BP texts
- New Supplementary Chapters containing general guidance on Unlicensed Medicines and Method Validation
- First BP monograph for Traditional Chinese Medicines
- All European Pharmacopoeia 5th edition material up to and including Supplement 5.5 integrated into the text of BP 2007
- Value-for-money networking with full technical support from the publishers
- CD-ROM and website deliver the complete text of the British Pharmacopoeia, British Approved Names and European Pharmacopoeia standards directly to your PC
Thursday, December 24, 2009
USP NF 2007 (United States Pharmacopeia/National Formulary)
![[uuu.jpg]](http://1.bp.blogspot.com/_WFLW5i5MYiI/RpHargKP_EI/AAAAAAAAABM/83uQjsjXh5g/s1600/uuu.jpg)
The United States Pharmacopeia is a compendium of quality control tests for drugs and excipients to be introduced into a medicinal formulation. It is published every year [1] by the United States Pharmacopoeial Convention. It forms the basis of enforcement actions by the U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration and is the official pharmacopoeia of the U.S.A. and many other nations. Therefore, in case of a dispute, those methods for, amongst others, identification, assay and purity determination of a drug substance or excipient which are stated in the USP will be the legally binding ones.
Within the field the compendium is referred to simply as the USP. The initials USP are affixed to materials' names to indicate that they conform to the specifications in the USP and may be used medicinally.
0 comments:
Post a Comment